American Vanguard Corporation $AVD Shares Bought by EVR Research LP

EVR Research LP lifted its position in shares of American Vanguard Corporation (NYSE:AVD) by 82.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 618,657 shares of the basic materials company’s stock after acquiring an additional 278,657 shares during the quarter. American Vanguard accounts for approximately 1.3% of EVR Research LP’s portfolio, making the stock its 24th largest holding. EVR Research LP owned about 2.17% of American Vanguard worth $2,363,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Cove Street Capital LLC raised its stake in shares of American Vanguard by 12.1% during the 3rd quarter. Cove Street Capital LLC now owns 1,398,986 shares of the basic materials company’s stock worth $8,030,000 after buying an additional 150,703 shares in the last quarter. Potomac Capital Management Inc. purchased a new stake in shares of American Vanguard in the fourth quarter valued at approximately $1,751,000. Legato Capital Management LLC acquired a new position in American Vanguard during the third quarter worth $697,000. Ironwood Investment Management LLC grew its holdings in American Vanguard by 42.1% during the fourth quarter. Ironwood Investment Management LLC now owns 55,056 shares of the basic materials company’s stock worth $210,000 after acquiring an additional 16,324 shares during the period. Finally, Acadian Asset Management LLC raised its position in American Vanguard by 1,732.4% in the first quarter. Acadian Asset Management LLC now owns 58,234 shares of the basic materials company’s stock worth $253,000 after acquiring an additional 55,056 shares in the last quarter. Institutional investors and hedge funds own 79.00% of the company’s stock.

Insider Transactions at American Vanguard

In other American Vanguard news, Director Patrick E. Gottschalk purchased 25,000 shares of American Vanguard stock in a transaction on Tuesday, May 19th. The shares were bought at an average price of $2.70 per share, with a total value of $67,500.00. Following the completion of the acquisition, the director directly owned 191,705 shares of the company’s stock, valued at approximately $517,603.50. This trade represents a 15.00% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 5.60% of the company’s stock.

American Vanguard Stock Performance

Shares of AVD stock opened at $2.60 on Thursday. The stock has a fifty day moving average price of $2.74 and a 200 day moving average price of $3.66. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.41 and a current ratio of 2.32. The stock has a market cap of $74.24 million, a PE ratio of -1.63 and a beta of 1.43. American Vanguard Corporation has a 1 year low of $2.05 and a 1 year high of $5.92.

American Vanguard (NYSE:AVD) last posted its earnings results on Wednesday, May 6th. The basic materials company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.08). American Vanguard had a negative net margin of 8.71% and a negative return on equity of 4.13%. The firm had revenue of $123.57 million during the quarter, compared to analyst estimates of $120.00 million.

Analyst Ratings Changes

Separately, Weiss Ratings cut shares of American Vanguard from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, May 18th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, American Vanguard has an average rating of “Sell”.

American Vanguard Profile

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.